| Ziltivekimab | ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack | Phase 3 | Active not recruiting | 10,000 | Jan 29, 2027 |
| Awiqli | A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes | Phase 3 | Active not recruiting | 877 | Jan 25, 2027 |
| NNC0662-0419 | A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity | Phase 2 | Active not recruiting | 224 | Dec 14, 2026 |
| Ziltivekimab | A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation | Phase 3 | Terminated | 4,874 | Sep 3, 2026 |
| Wegovy | A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes | Phase 3 | Completed | 267 | Jun 29, 2026 |
| Semaglutide and Behavioral Program | Lifestyle Counseling and Medication for Adolescent Weight Management | Phase 2 | Completed · results | 121 | Jun 29, 2026 |
| CagriSema | A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy | Phase 2 | Completed | 142 | Jun 26, 2026 |
| Ziltivekimab B | ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation | Phase 3 | Completed | 6,385 | Jun 9, 2026 |
| Wegovy | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both | Phase 3 | Completed | 1,023 | Jun 2, 2026 |
| Wegovy | Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves | Phase 2 | Completed | 160 | Apr 29, 2026 |
| Wegovy | A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight | Phase 3 | Completed | 300 | Apr 22, 2026 |
| etavopivat | Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease | Phase 2 | Completed | 12 | Mar 9, 2026 |
| Wegovy | A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects | Phase 3 | Completed | 408 | Mar 7, 2026 |
| Wegovy | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor | Phase 3 | Completed | 1,024 | Mar 4, 2026 |
| Wegovy | A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight | Phase 3 | Completed | 809 | Dec 8, 2025 |
| Victoza | Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome | Phase 3 | Completed | 183 | Nov 30, 2025 |
| Wegovy | Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease | Phase 2 | Completed | 270 | Nov 21, 2025 |
| Wegovy | A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor | Phase 3 | Completed | 2,734 | Nov 19, 2025 |
| Wegovy | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise | Phase 3 | Completed | 189 | Oct 1, 2025 |
| NNC0487-0111 subcutanous | A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes | Phase 2 | Completed | 448 | Oct 1, 2025 |
| Wegovy | A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo | Phase 2 | Completed | 626 | Sep 24, 2025 |
| NNC0519-0130 | A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes | Phase 2 | Completed | 299 | Sep 19, 2025 |
| Wegovy | A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) | Phase 3 | Completed | 1,840 | Sep 16, 2025 |
| Wegovy | A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) | Phase 3 | Completed | 1,840 | Sep 15, 2025 |
| Wegovy | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin | Phase 3 | Completed | 274 | Sep 9, 2025 |
| insulin glargine | Effect of Topical Insulin on Healing Rate of Pemphigus Lesions | Phase 2 | Completed | 20 | Aug 10, 2025 |
| NDec - oral decitabine-tetrahydrouridine | Research Study Investigating How Well NDec Works in People With Sickle Cell Disease | Phase 2 | Completed | 96 | Jul 24, 2025 |
| Kyinsu | A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4) | Phase 3 | Completed | 485 | May 27, 2025 |
| Awiqli | A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes | Phase 3 | Completed · results | 412 | May 8, 2025 |
| Wegovy | A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes | Phase 3 | Completed · results | 132 | Apr 29, 2025 |
| Wegovy | A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects. | Phase 2 | Completed | 60 | Apr 25, 2025 |
| Awiqli | A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes | Phase 3 | Completed · results | 148 | Apr 14, 2025 |
| NNC0519-0130 | A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight | Phase 2 | Completed | 354 | Apr 10, 2025 |
| Wegovy | Semaglutide 2.4 mg in Patients With Poor Weight-loss | Phase 3 | Completed · results | 70 | Apr 9, 2025 |
| Wegovy | A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range | Phase 3 | Completed · results | 242 | Apr 2, 2025 |
| Wegovy | A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) | Phase 3 | Completed · results | 573 | Mar 5, 2025 |
| NNC6019-0001 | A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis | Phase 2 | Completed | 105 | Feb 17, 2025 |
| nedosiran | Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function | Phase 2 | Completed · results | 27 | Feb 5, 2025 |
| Wegovy | A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) | Phase 3 | Completed · results | 1,407 | Oct 30, 2024 |